Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy
by on Saturday, June 23rd, 2012 | No Comments
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: Bendamustine; Drug: Ofatumumab
Sponsors: Sarah Cannon Research Institute; Sarah Cannon Research Institute; GlaxoSmithKline; Cephalon
Not yet recruiting – verified June 2012
See the original post here: Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy